These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9711782)

  • 61. Lack of correlation between phenotype activation markers of CD8 lymphocytes and cytotoxic T lymphocyte (CTL) function in HIV-1 infection: evidence for rescue with rIL-2.
    Chia WK; Nisbet-Brown E; Li X; Salit I; Joshi S; Read SE
    Viral Immunol; 1994; 7(2):81-95. PubMed ID: 7848511
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses.
    Yu XG; Shang H; Addo MM; Eldridge RL; Phillips MN; Feeney ME; Strick D; Brander C; Goulder PJ; Rosenberg ES; Walker BD; Altfeld M;
    AIDS; 2002 Feb; 16(3):321-8. PubMed ID: 11834942
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men.
    Rinaldo CR; Beltz LA; Huang XL; Gupta P; Fan Z; Torpey DJ
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):481-9. PubMed ID: 7632463
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
    Jin X; Ogg G; Bonhoeffer S; Safrit J; Vesanen M; Bauer D; Chen D; Cao Y; Demoitie MA; Zhang L; Markowitz M; Nixon D; McMichael A; Ho DD
    Mol Med; 2000 Sep; 6(9):803-9. PubMed ID: 11071274
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys.
    Voss G; Li J; Manson K; Wyand M; Sodroski J; Letvin NL
    Virology; 1995 Apr; 208(2):770-5. PubMed ID: 7747449
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In HIV type 1-infected children cytotoxic T lymphocyte responses are associated with greater reduction of viremia under antiretroviral therapy.
    Buseyne F; Le Chenadec J; Burgard M; Bellal N; Mayaux MJ; Rouzioux C; Rivière Y; Blanche S
    AIDS Res Hum Retroviruses; 2005 Aug; 21(8):719-27. PubMed ID: 16131312
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression.
    Dalod M; Fiorentino S; Delamare C; Rouzioux C; Sicard D; Guillet JG; Gomard E
    AIDS Res Hum Retroviruses; 1996 Apr; 12(6):497-506. PubMed ID: 8679305
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals.
    Yu Q; Gu JX; Kovacs C; Freedman J; Thomas EK; Ostrowski MA
    J Immunol; 2003 Feb; 170(4):1797-805. PubMed ID: 12574344
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Functional Analyses of HIV-1 Specific Cytotoxic T Lymphocyte Clones].
    Jin C; Tu T; Mou D; Li Q; Song X; Zhang H; Tang T; Li T; Wu H; Chen H
    Bing Du Xue Bao; 2016 May; 32(3):331-41. PubMed ID: 29963819
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assessing the antiviral activity of HIV-1-specific cytotoxic T lymphocytes.
    Yang OO
    Methods Mol Biol; 2009; 485():407-15. PubMed ID: 19020840
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children.
    Buseyne F; Chaix ML; Rouzioux C; Blanche S; Rivière Y
    J Virol; 2001 May; 75(10):4941-6. PubMed ID: 11312369
    [TBL] [Abstract][Full Text] [Related]  

  • 73. HIV and children: the developing immune system fights back.
    Feeney ME
    West Indian Med J; 2004 Oct; 53(5):359-62. PubMed ID: 15675505
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic significance of immunologic changes in 675 infants perinatally exposed to human immunodeficiency virus. The Italian Register for Human Immunodeficiency Virus Infection in Children.
    de Martino M; Tovo PA; Galli L; Gabiano C; Cozzani S; Gotta C; Scarlatti G; Fiocchi A; Cocchi P; Marchisio P
    J Pediatr; 1991 Nov; 119(5):702-9. PubMed ID: 1682435
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.
    McAdam S; Kaleebu P; Krausa P; Goulder P; French N; Collin B; Blanchard T; Whitworth J; McMichael A; Gotch F
    AIDS; 1998 Apr; 12(6):571-9. PubMed ID: 9583596
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age.
    Buseyne F; Janvier G; Teglas JP; Ivanoff S; Burgard M; Bui E; Mayaux MJ; Blanche S; Rouzioux C; Rivière Y
    J Infect Dis; 1998 Oct; 178(4):1019-23. PubMed ID: 9806029
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Suppression of HIV-1 replication by HIV-1-irrelevant CD8+ cytotoxic T lymphocytes resulting in preservation of persistently HIV-1-infected cells in vitro.
    Liu H; Ohashi T; Masuda T; Zhou X; Kubo M; Kannagi M
    Viral Immunol; 2003; 16(3):381-93. PubMed ID: 14583152
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal.
    Legrand FA; Nixon DF; Loo CP; Ono E; Chapman JM; Miyamoto M; Diaz RS; Santos AM; Succi RC; Abadi J; Rosenberg MG; de Moraes-Pinto MI; Kallas EG
    PLoS One; 2006 Dec; 1(1):e102. PubMed ID: 17183635
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Genetic evaluation of suspected cases of transient HIV-1 infection of infants.
    Frenkel LM; Mullins JI; Learn GH; Manns-Arcuino L; Herring BL; Kalish ML; Steketee RW; Thea DM; Nichols JE; Liu SL; Harmache A; He X; Muthui D; Madan A; Hood L; Haase AT; Zupancic M; Staskus K; Wolinsky S; Krogstad P; Zhao J; Chen I; Koup R; Ho D; Korber B; Apple RJ; Coombs RW; Pahwa S; Roberts NJ
    Science; 1998 May; 280(5366):1073-7. PubMed ID: 9582120
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children.
    Buseyne F; Le Chenadec J; Corre B; Porrot F; Burgard M; Rouzioux C; Blanche S; Mayaux MJ; Rivière Y
    J Infect Dis; 2002 Dec; 186(11):1589-96. PubMed ID: 12447734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.